Bausch Health Companies Inc. (BHC)

5.77 0.04 (0.7%)

As of 2026-03-03 17:47:39 EST

Bausch Health Companies Inc. (formerly Valeant and ICN Pharmaceuticals) is a global, diversified American-Canadian pharmaceutical company. Its global corporate headquarters are located in Laval, Quebec, Canada, and its U.S. headquarters are in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neurology, dermatology, dentistry, medical aesthetics, and international pharmaceuticals. Bausch Health manufactures and markets branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America.

Traded asNYSE: BHC
ISINCA0717341071
CIK0000885590
LEIB3BS7ACMDUWISF18KY76
EIN—
SectorPharmaceuticals
IndustryPharmaceutical Preparations
CEOThomas J. Appio
Employees7,000
Fiscal Year End1231
Address2150 ST. ELZEAR BLVD. WEST, QUEBEC, A8, H7L 4A8
Phone514-744-6792
Websitehttp://bauschhealth.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
BHCBausch Health Companies Inc.2026-03-03 17:47:395.770.040.7
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
BHC0000885590Bausch Health Companies Inc.CA0717341071B3BS7ACMDUWISF18KY76—NYSE2834Pharmaceutical Preparations1231NJ2150 ST. ELZEAR BLVD. WESTQUEBECA8H7L 4A8CANADACA514-744-67922150 ST. ELZEAR BLVD. WEST, QUEBEC, A8, H7L 4A82150 ST. ELZEAR BLVD. WEST, QUEBEC, A8, H7L 4A8Valeant Pharmaceuticals International, Inc.Pharmaceuticals1959Thomas J. Appio7,000http://bauschhealth.com2,004,729,038370,531,987370,562,428Bausch Health Companies Inc. (formerly Valeant and ICN Pharmaceuticals) is a global, diversified American-Canadian pharmaceutical company. Its global corporate headquarters are located in Laval, Quebec, Canada, and its U.S. headquarters are in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neurology, dermatology, dentistry, medical aesthetics, and international pharmaceuticals. Bausch Health manufactures and markets branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America.2026-02-26 17:19:46
This is a preview of the latest data. Subscribe to access the full data.
BHC Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
BHC Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
20252,004,729,038-121,008,459-5.6925370,562,4282,628,5310.7144
20242,125,737,497-292,820,831-12.1072367,933,8972,521,9440.6902
20232,418,558,328-88,563,889-3.5325365,411,9533,374,7620.9322
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Seana CarsonExecutive Vice President, General Counsel2024579,67002,950,720433,1508,9393,972,479
Aimee J. LenarExecutive Vice President2024300,000400,0001,056,657227,5302,2501,986,437
Thomas J. AppioChief Executive Officer20241,226,308013,141,5741,854,00017,25116,239,133
Jean-Jaques CharhonChief Financial Officer, Executive Vice President2024255,769300,0003,526,288185,03004,267,087
John S. BarresiChief Financial Officer, Controller, Chief Accounting Officer, Senior Vice President2024553,15450,0001,007,639337,80026,5251,975,118
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
202520,300
202420,700
202320,270
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202520242023
Revenue10,266,000,0009,625,000,0008,757,000,000
Cost Of Revenue2,949,000,0002,729,000,0002,519,000,000
Gross Profit———
Research And Development Expenses629,000,000616,000,000604,000,000
General And Administrative Expenses3,438,000,0003,296,000,0002,917,000,000
Operating Expenses8,453,000,0008,079,000,0007,794,000,000
Operating Income1,813,000,0001,546,000,000963,000,000
Net Income157,000,000-46,000,000-592,000,000
Earnings Per Share Basic0.42-0.13-1.62
Earnings Per Share Diluted0.42-0.13-1.62
Weighted Average Shares Outstanding Basic370,900,000368,000,000364,900,000
Weighted Average Shares Outstanding Diluted375,000,000368,000,000364,900,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202520242023
Cash And Cash Equivalents1,309,000,0001,181,000,000947,000,000
Marketable Securities Current———
Accounts Receivable2,351,000,0002,140,000,0001,998,000,000
Inventories1,629,000,0001,595,000,0001,544,000,000
Non Trade Receivables———
Other Assets Current———
Total Assets Current6,157,000,0005,774,000,0005,596,000,000
Marketable Securities Non Current———
Property Plant And Equipment2,074,000,0001,780,000,0001,707,000,000
Other Assets Non Current378,000,000363,000,000307,000,000
Total Assets Non Current2,074,000,0001,780,000,0001,707,000,000
Total Assets26,366,000,00026,523,000,00027,350,000,000
Accounts Payable600,000,000656,000,000719,000,000
Deferred Revenue———
Short Term Debt225,000,0002,674,000,000450,000,000
Other Liabilities Current3,344,000,0003,422,000,0003,133,000,000
Total Liabilities Current4,180,000,0006,752,000,0004,302,000,000
Long Term Debt20,817,000,00021,616,000,00022,388,000,000
Other Liabilities Non Current793,000,000713,000,000776,000,000
Total Liabilities Non Current21,809,000,00020,093,000,00023,130,000,000
Total Liabilities25,989,000,00026,845,000,00027,432,000,000
Common Stock10,516,000,00010,490,000,00010,423,000,000
Retained Earnings-9,667,000,000-9,824,000,000-9,778,000,000
Accumulated Other Comprehensive Income-1,760,000,000-2,179,000,000-1,881,000,000
Total Shareholders Equity-554,000,000-1,279,000,000-1,022,000,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202520242023
Depreciation And Amortization1,208,000,0001,267,000,0001,264,000,000
Share Based Compensation Expense216,000,000150,000,000132,000,000
Other Non Cash Income Expense———
Change In Accounts Receivable134,000,000216,000,000195,000,000
Change In Inventories12,000,000267,000,000322,000,000
Change In Non Trade Receivables———
Change In Other Assets———
Change In Accounts Payable-76,000,000357,000,000158,000,000
Change In Other Liabilities———
Cash From Operating Activities1,400,000,0001,597,000,0001,032,000,000
Purchases Of Marketable Securities11,000,00012,000,00027,000,000
Sales Of Marketable Securities8,000,00014,000,00026,000,000
Acquisition Of Property Plant And Equipment397,000,000337,000,000215,000,000
Acquisition Of Business——1,890,000,000
Other Investing Activities———
Cash From Investing Activities-595,000,000-454,000,000-2,145,000,000
Tax Withholding For Share Based Compensation24,000,00026,000,00024,000,000
Payments Of Dividends———
Issuance Of Common Stock———
Repurchase Of Common Stock———
Issuance Of Long Term Debt10,554,000,000661,000,0003,291,000,000
Repayment Of Long Term Debt11,191,000,0001,460,000,0001,710,000,000
Other Financing Activities-10,000,000-11,000,000-11,000,000
Cash From Financing Activities-742,000,000-868,000,0001,475,000,000
Change In Cash124,000,000239,000,000371,000,000
Cash At End Of Period1,309,000,0001,181,000,000947,000,000
Income Taxes Paid163,000,00061,000,000237,000,000
Interest Paid1,810,000,0001,674,000,0001,533,000,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202520242023
Earnings Per Share0.42-0.13-1.62
Price To Earnings Ratio16.5476-62-4.9506
Earnings Growth Rate-423.0769-91.9753161.2903
Price Earnings To Growth Ratio-0.03910.6741-0.0307
Book Value Per Share1.0164-0.875-0.2247
Price To Book Ratio6.8375-9.2114-35.689
Ebitda3,132,000,0002,670,000,0002,237,000,000
Enterprise Value22,310,755,00026,075,080,00024,817,498,000
Dividend Yield———
Dividend Payout Ratio———
Debt To Equity Ratio-37.9819-18.9914-22.3464
Capital Expenditures1,502,000,0001,340,000,0001,371,000,000
Free Cash Flow-102,000,000257,000,000-339,000,000
Return On Equity-0.28340.0360.5793
One Year Beta0.88080.93571.6978
Three Year Beta1.09251.38381.4054
Five Year Beta1.22031.34471.3685
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
Carson SeanaEVP, General Counsel2026-03-034,420D616,761
APPIO THOMASDirector, Chief Executive Officer2026-03-0283,705D3,453,236
APPIO THOMASDirector, Chief Executive Officer2026-03-021,137,862D2,315,374
Carson SeanaEVP, General Counsel2026-03-026,856D776,076
Carson SeanaEVP, General Counsel2026-03-0216,973D759,103
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Susie Lee2020-10-07NV03Sale2020-08-27Joint$1,001 - $15,000
Susie Lee2020-04-28NV03Purchase2020-02-24Joint$1,001 - $15,000
Susie Lee2020-02-25NV03Purchase2020-01-06Joint$1,001 - $15,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
Caitong International Asset Management Co., Ltd2025-12-3169,90310,0586.95
Aristides Capital LLC2025-12-31199,04128,6396.95
Bell Investment Advisors, Inc2025-12-311,0291486.9527
Invesco Ltd.2025-12-311,241,319178,6076.95
State of Tennessee, Department of Treasury2025-12-31266,45146,4205.74
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
SCM Trust2025-12-31Institutional ClassSISEX43,141299,535.710.72
SCM Trust2025-12-31Investor ClassSISLX43,141299,535.710.72
UPRIGHT INVESTMENTS TRUST2025-12-31Upright Growth FundUPUPX2,00013,9000.06
BRUCE FUND INC2025-12-31BRUCE FUNDBRUFX50,000347,5000.0999
GABELLI ASSET FUND2025-12-31CLASS IGABIX7,00048,6500.0031
This is a preview of the latest data. Subscribe to access the full data.